William S Azar

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Diabetic Nephropathy

Cardiovascular Disease

Glycemic Control

Aortic Stenosis

Top Venues

Journal of molecular endocrinology

This page only lists publications with an associated author ORCID identifier.

Publications

Layal Abou Assi, Sahar Alkhansa, Rachel Njeim, Jaafar Ismail, Mikel Madi, Hilda E Ghadieh, Sarah Al Moussawi, Tanya S Azar, Maurice Ayoub, William S Azar, Sarah Hamade, Rashad Nawfal, Nina-Rossa Haddad, Frederic Harb, Wissam H Faour, Mahmoud Ibrahim Khalil, Assaad A Eid
Uncovering the Therapeutic Potential of Lithium Chloride in Type 2 Diabetic Cardiomyopathy: Targeting Tau Hyperphosphorylation and TGF-β Signaling via GSK-3β Inhibition. Pharmaceutics 16 (7) (2024)
Layal Abou Assi, Sahar Alkhansa, Rachel Njeim, Jaafar Ismail, Mikel Madi, Hilda E Ghadieh, Sarah Al Moussawi, Tanya S Azar, Maurice Ayoub, William S Azar, Sarah Hamade, Rashad Nawfal, Nina-Rossa Haddad, Frederic Harb, Wissam H Faour, Mahmoud Ibrahim Khalil, Assaad A Eid
Uncovering the Therapeutic Potential of Lithium Chloride in Type 2 Diabetic Cardiomyopathy: Targeting Tau Hyperphosphorylation and TGF-β Signaling via GSK-3β Inhibition. Pharmaceutics 16 (7) (2024)
Layal Abou Assi, Sahar Alkhansa, Rachel Njeim, Jaafar Ismail, Mikel Madi, Hilda E Ghadieh, Sarah Al Moussawi, Tanya S Azar, Maurice Ayoub, William S Azar, Sarah Hamade, Rashad Nawfal, Nina-Rossa Haddad, Frederic Harb, Wissam H Faour, Mahmoud Ibrahim Khalil, Assaad A Eid
Uncovering the Therapeutic Potential of Lithium Chloride in Type 2 Diabetic Cardiomyopathy: Targeting Tau Hyperphosphorylation and TGF-β Signaling via GSK-3β Inhibition. Pharmaceutics 16 (7) (2024)
Batoul Dia, Sahar Alkhansa, Rachel Njeim, Sarah Al Moussawi, Theresa Farhat, Antony Haddad, Mansour E Riachi, Rashad Nawfal, William S Azar, Assaad A Eid
SGLT2 Inhibitor-Dapagliflozin Attenuates Diabetes-Induced Renal Injury by Regulating Inflammation through a CYP4A/20-HETE Signaling Mechanism. Pharmaceutics 15 (3) (2023)
Batoul Dia, Sahar Alkhansa, Rachel Njeim, Sarah Al Moussawi, Theresa Farhat, Antony Haddad, Mansour E Riachi, Rashad Nawfal, William S Azar, Assaad A Eid
SGLT2 Inhibitor-Dapagliflozin Attenuates Diabetes-Induced Renal Injury by Regulating Inflammation through a CYP4A/20-HETE Signaling Mechanism. Pharmaceutics 15 (3) (2023)
Batoul Dia, Sahar Alkhansa, Rachel Njeim, Sarah Al Moussawi, Theresa Farhat, Antony Haddad, Mansour E Riachi, Rashad Nawfal, William S Azar, Assaad A Eid
SGLT2 Inhibitor-Dapagliflozin Attenuates Diabetes-Induced Renal Injury by Regulating Inflammation through a CYP4A/20-HETE Signaling Mechanism. Pharmaceutics 15 (3) (2023)
Rachel Njeim, William S Azar, Angie H Fares, Sami T Azar, Hala Kfoury Kassouf, Assaad A Eid
NETosis contributes to the pathogenesis of diabetes and its complications. Journal of molecular endocrinology 65 (4) (2021)